Colibri Heart Valve LLC
Pre-packaged TAVI system
This article was originally published in Start Up
Colibri Heart Valve LLC has developed a pre-packaged and sterilized aortic heart valve that it thinks will further propel the transcatheter aortic heart valve implantation (TAVI) market. Its ready-for-use device has a profile that is roughly 20% to 40% less than the current market leaders, so patients with smaller femoral arteries who are currently excluded can benefit from TAVI.
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."